CLOV Clover Health Investments Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: CLOV

Price (delayed)

$4.57

Market cap

$2.43B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.05

Enterprise value

$2.23B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 33
Highlights
The net income has soared by 68% since the previous quarter and by 57% year-on-year
CLOV's EPS has surged by 58% since the previous quarter and by 38% year-on-year
Clover Health Investments's quick ratio has decreased by 20% YoY but it has increased by 20% QoQ
Clover Health Investments's gross margin has decreased by 22% YoY
Sector: Healthcare
Industry: Healthcare Plans
Website: http://www.cloverhealth.com
Peers: PHR PHUN

Key stats

What are the main financial stats of CLOV

CLOV stock price

How has the Clover Health Investments stock price performed over time
Intraday
-2.14%
1 week
0.22%
1 month
10.12%
1 year
40.62%
YTD
94.47%
QTD
-12.79%

Financial performance

How have Clover Health Investments's revenue and profit performed over time
Revenue
$2.48B
Gross profit
$459.93M
Operating income
-$18.36M
Net income
-$18.36M
Gross margin
18.6%
Net margin
-0.7%
The net margin has soared by 74% YoY and by 73% from the previous quarter
Clover Health Investments's operating margin has soared by 73% from the previous quarter and by 73% YoY
The net income has soared by 68% since the previous quarter and by 57% year-on-year
The operating income has soared by 68% from the previous quarter and by 56% YoY

Price vs fundamentals

How does CLOV's price correlate with its fundamentals

Growth

What is Clover Health Investments's growth rate over time

Valuation

What is Clover Health Investments stock price valuation
P/E
N/A
P/B
6.4
P/S
0.97
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.9
CLOV's EPS has surged by 58% since the previous quarter and by 38% year-on-year
The P/B is 98% above the 5-year quarterly average of 3.3 and 42% above the last 4 quarters average of 4.6
The equity has grown by 11% from the previous quarter and by 9% YoY
The revenue has soared by 54% YoY and by 12% from the previous quarter
The P/S is 53% below the 5-year quarterly average of 2.1 but 24% above the last 4 quarters average of 0.8

Efficiency

How efficient is Clover Health Investments business performance
CLOV's return on sales has surged by 74% year-on-year and by 73% since the previous quarter
The ROA has soared by 70% from the previous quarter and by 60% YoY
The return on invested capital has surged by 68% since the previous quarter and by 66% year-on-year
CLOV's ROE has soared by 68% from the previous quarter and by 57% YoY

Dividends

What is CLOV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CLOV.

Financial health

How did Clover Health Investments financials performed over time
CLOV's total assets is 109% greater than its total liabilities
Clover Health Investments's total liabilities has increased by 49% YoY but it has decreased by 4% from the previous quarter
CLOV's total assets is up by 25% year-on-year and by 3.2% since the previous quarter
The debt is 100% less than the equity
The equity has grown by 11% from the previous quarter and by 9% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.